[go: up one dir, main page]

NO920958D0 - Toerre farmasoeytiske lav-dose-preparater - Google Patents

Toerre farmasoeytiske lav-dose-preparater

Info

Publication number
NO920958D0
NO920958D0 NO920958A NO920958A NO920958D0 NO 920958 D0 NO920958 D0 NO 920958D0 NO 920958 A NO920958 A NO 920958A NO 920958 A NO920958 A NO 920958A NO 920958 D0 NO920958 D0 NO 920958D0
Authority
NO
Norway
Prior art keywords
disclosed
weight
agent
dry
tablet
Prior art date
Application number
NO920958A
Other languages
English (en)
Other versions
NO305055B1 (no
NO920958L (no
Inventor
Pieter De Haan
Marcus Johannes Deurloo
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO920958(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO920958D0 publication Critical patent/NO920958D0/no
Publication of NO920958L publication Critical patent/NO920958L/no
Publication of NO305055B1 publication Critical patent/NO305055B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO920958A 1991-03-12 1992-03-11 Farmas°ytisk t°rr blanding, farmas°ytisk doseringsenhet, fremgangsmÕte ved fremstilling derav og fremgangsmÕte ved fremstilling av tabletter NO305055B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200524 1991-03-12

Publications (3)

Publication Number Publication Date
NO920958D0 true NO920958D0 (no) 1992-03-11
NO920958L NO920958L (no) 1992-09-14
NO305055B1 NO305055B1 (no) 1999-03-29

Family

ID=8207548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920958A NO305055B1 (no) 1991-03-12 1992-03-11 Farmas°ytisk t°rr blanding, farmas°ytisk doseringsenhet, fremgangsmÕte ved fremstilling derav og fremgangsmÕte ved fremstilling av tabletter

Country Status (18)

Country Link
US (1) US5382434A (no)
EP (1) EP0503521B2 (no)
JP (1) JP3474210B2 (no)
KR (1) KR100198017B1 (no)
CN (1) CN1039086C (no)
AT (1) ATE125155T1 (no)
AU (1) AU651869B2 (no)
CA (1) CA2062428C (no)
DE (1) DE69203488T3 (no)
DK (1) DK0503521T4 (no)
ES (1) ES2077897T5 (no)
FI (1) FI100770B (no)
GR (1) GR3017737T3 (no)
HK (1) HK1002018A1 (no)
IE (1) IE67345B1 (no)
NO (1) NO305055B1 (no)
NZ (1) NZ241915A (no)
ZA (1) ZA921659B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924617B (en) 1991-03-25 1994-05-27 Boart International S A Pty Lt A percussion drill bit
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US5928668A (en) * 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
JP4334616B2 (ja) * 1994-09-22 2009-09-30 ナームローゼ・フエンノートチヤツプ・オルガノン 湿式粒状化による投与単位体を製造する方法
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997026798A1 (en) * 1995-01-25 1997-07-31 Wm. Wrigley Jr. Company Improved rolling compound and methods of manufacturing chewing gum using same
HU223943B1 (hu) * 1995-06-22 2005-03-29 Akzo Nobel N.V. Dezogesztrelt tartalmazó, szárazon granulált, sajtolt tabletták és előállításuk
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
AU2669700A (en) * 1999-02-24 2000-09-14 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna- 4,15-dien-20-yn-3-one (org 30659) and lactose
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
DE19917347A1 (de) 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
ITMI991582A1 (it) * 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
US7078057B2 (en) * 1999-12-20 2006-07-18 Kerkhof Nicholas J Process for producing nanometer particles by fluid bed spray-drying
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
WO2002008470A1 (en) * 2000-07-20 2002-01-31 Campina B.V. Method for producing a crystalline tableting additive, additive thus obtained and use thereof
CZ306435B6 (cs) * 2000-12-14 2017-01-25 Ortho-Mcneil Pharmaceutical, Inc. Steroidní hormonální přípravek a způsob jeho přípravy
KR20030081472A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
CN1494434A (zh) * 2001-03-06 2004-05-05 Э�ͷ��͹�ҵ��ʽ���� 含糖醇喷雾干燥粉末的用途
IL158390A0 (en) * 2001-05-01 2004-05-12 Pfizer Prod Inc Method for manufacturing a low dose pharmaceutical composition
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
ATE461681T1 (de) 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2178540A4 (en) * 2007-08-01 2012-01-04 Stellan Hjerten PHARMACEUTICAL COMPOSITION FOR ADSORBED ON THE CELL SURFACE OF PATHOGENIC MICROBES
CA2739887A1 (en) * 2008-10-10 2010-04-15 Teva Women's Health, Inc. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
US8617588B2 (en) 2009-03-09 2013-12-31 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
EP2354150A1 (en) * 2010-02-09 2011-08-10 Laboratoire Theramex Process for the preparation of gestodene
WO2012120365A1 (en) 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
CN102416003A (zh) * 2011-12-08 2012-04-18 南京优科生物医药有限公司 一种制备恩替卡韦片剂的方法
WO2014137877A1 (en) * 2013-03-04 2014-09-12 Besins Healthcare Luxembourg Sarl Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US3802914A (en) * 1972-04-10 1974-04-09 Kraftco Corp Method of treating lactose
SE378109B (no) * 1972-05-19 1975-08-18 Bofors Ab
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2524902C2 (de) * 1975-06-02 1984-10-25 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
US4143136A (en) * 1976-11-20 1979-03-06 Akzona Incorporated Method of contraception
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide

Also Published As

Publication number Publication date
NO305055B1 (no) 1999-03-29
DE69203488D1 (de) 1995-08-24
JP3474210B2 (ja) 2003-12-08
KR920017656A (ko) 1992-10-21
HK1002018A1 (en) 1998-07-24
KR100198017B1 (ko) 1999-06-15
FI100770B (fi) 1998-02-27
ATE125155T1 (de) 1995-08-15
ES2077897T3 (es) 1995-12-01
GR3017737T3 (en) 1996-01-31
ZA921659B (en) 1992-11-25
FI921023A0 (fi) 1992-03-09
FI921023L (fi) 1992-09-13
EP0503521A1 (en) 1992-09-16
CA2062428A1 (en) 1992-09-13
EP0503521B2 (en) 2005-11-09
US5382434A (en) 1995-01-17
NO920958L (no) 1992-09-14
ES2077897T5 (es) 2006-06-16
CN1039086C (zh) 1998-07-15
AU1211992A (en) 1992-09-17
CA2062428C (en) 2002-07-30
DK0503521T4 (da) 2005-12-05
IE920634A1 (en) 1992-09-23
AU651869B2 (en) 1994-08-04
JPH0578251A (ja) 1993-03-30
IE67345B1 (en) 1996-03-20
DE69203488T3 (de) 2006-07-06
EP0503521B1 (en) 1995-07-19
DE69203488T2 (de) 1996-01-11
CN1064810A (zh) 1992-09-30
DK0503521T3 (da) 1995-11-27
NZ241915A (en) 1994-04-27

Similar Documents

Publication Publication Date Title
NO920958D0 (no) Toerre farmasoeytiske lav-dose-preparater
US3344029A (en) Sustained release composition
IE891414L (en) Pharmaceutical compositions
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NZ236834A (en) Oral medicaments comprising pimobendan in dry mixture with citric acid
NO922807D0 (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
EP0391374A3 (en) Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
DK0456720T3 (da) Granuleringer med højt ibuprofenindhold
GB1427881A (en) Mixtures containing nitroglycerin and polyvinyl-pyrrolidone
HU9302971D0 (en) Chewable antacid preparations
ZA939565B (en) Method for preparing low dose pharmaceutical products.
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
WO2001010415B1 (en) A binder for pharmaceutical compositions
GB1255805A (en) Improvements in delayed release pharmaceutical preparations and stabilisation of vitamins
NO176948C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i enhetsdoseform omfattende finmalt colestipol-hydroklorid
ATE90555T1 (de) Scleroglucan und wirkstoff enthaltende pharmazeutische tabletten und kapselgranulate.
EP0367509A3 (en) Formulations
Fateeva Pharmacokinetics of amphoglucamine in an experiment
JPS57176907A (en) Readily absorbable solid pharmaceutical composition of as-56c
JPS5462327A (en) Remedy for dna virus infectious disease
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
CA2176461A1 (en) Method for preparing low dose pharmaceutical products

Legal Events

Date Code Title Description
MK1K Patent expired